Product Details
Product Name:
Imirestat |
CAS No.:
89391-50-4 |
Purity:
99.08% |
Supply Ability:
10g |
Release date:
2024/11/07 |
Product Introduction
Bioactivity
名稱 | Imirestat |
描述 | Imirestat (HOE 843) is an aldose reductase inhibitor that can be used in diabetes research. |
體內(nèi)活性 | Administration of 1 mg/kg Imirestat increased nerve conduction velocity, however, had no effect on resistance to hypoxic conduction block or deficits in insulin-stimulated Uban-sensitive ATPase activity[1]. |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 100 mg/mL (349.37 mM)
|
關鍵字 | Inhibitor | inhibit | Imirestat | HOE-843 | HOE843 | Aldose Reductase | Alcon-1576 | Alcon1576 | AL-1576 | AL1576 |
相關產(chǎn)品 | MK 0434 | Alconil | Epalrestat | D-Methionine sulfoxide | 2-Chloro-1-(4-fluorobenzyl)benzimidazole | Tolrestat | Lidorestat | Alpha-Estradiol | Isoliquiritigenin | Finasteride | Epristeride | Dutasteride |
相關庫 | 糖代謝化合物庫 | 經(jīng)典已知活性庫 | ReFRAME 相關化合物庫 | 抗糖尿病庫 | 抑制劑庫 | 內(nèi)分泌激素分子庫 | 代謝化合物庫 | 已知活性化合物庫 | 含氟化合物庫 | 人代謝物化合物庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
-
CAS:2210228-45-6
$41.00 / 1mg
-
CAS:83657-22-1
$33.00 / 500mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |